CS252828B2 - Method of n,3-disubstituted 2-oxindole-1-carboxamides production - Google Patents

Method of n,3-disubstituted 2-oxindole-1-carboxamides production Download PDF

Info

Publication number
CS252828B2
CS252828B2 CS853202A CS320285A CS252828B2 CS 252828 B2 CS252828 B2 CS 252828B2 CS 853202 A CS853202 A CS 853202A CS 320285 A CS320285 A CS 320285A CS 252828 B2 CS252828 B2 CS 252828B2
Authority
CS
Czechoslovakia
Prior art keywords
thienyl
formula
group
furyl
butyl
Prior art date
Application number
CS853202A
Other languages
Czech (cs)
English (en)
Other versions
CS320285A2 (en
Inventor
Saul B Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to CS861189A priority Critical patent/CS252847B2/cs
Publication of CS320285A2 publication Critical patent/CS320285A2/cs
Publication of CS252828B2 publication Critical patent/CS252828B2/cs

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/34Oxygen atoms in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/60Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/58[b]- or [c]-condensed
    • C07D209/70[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS853202A 1984-05-04 1985-05-04 Method of n,3-disubstituted 2-oxindole-1-carboxamides production CS252828B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS861189A CS252847B2 (cs) 1984-05-04 1986-02-20 Způsob výroby N,3-disubstituovaných 2-oxindol-1-karboxamidů

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
CS320285A2 CS320285A2 (en) 1987-03-12
CS252828B2 true CS252828B2 (en) 1987-10-15

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
CS853202A CS252828B2 (en) 1984-05-04 1985-05-04 Method of n,3-disubstituted 2-oxindole-1-carboxamides production

Country Status (25)

Country Link
JP (1) JPS60243068A (fi)
KR (1) KR870000497B1 (fi)
AR (1) AR241159A1 (fi)
BG (2) BG60208B2 (fi)
CS (1) CS252828B2 (fi)
DD (1) DD232916A5 (fi)
EG (1) EG17193A (fi)
ES (2) ES8609248A1 (fi)
FI (1) FI80016C (fi)
HU (1) HU196057B (fi)
IE (1) IE851103L (fi)
IN (1) IN161509B (fi)
MA (1) MA20424A1 (fi)
MW (1) MW1685A1 (fi)
MX (1) MX5839A (fi)
NO (1) NO163132C (fi)
OA (1) OA08098A (fi)
PL (2) PL147508B1 (fi)
PT (1) PT80375B (fi)
RO (2) RO91141B (fi)
RU (1) RU2017729C1 (fi)
SU (1) SU1468413A3 (fi)
YU (1) YU44998B (fi)
ZA (1) ZA853324B (fi)
ZW (1) ZW7885A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
HU196057B (en) 1988-09-28
FI80016B (fi) 1989-12-29
ES551275A0 (es) 1987-07-16
FI80016C (fi) 1990-04-10
MX5839A (es) 1993-11-01
BG60207B2 (en) 1993-12-30
DD232916A5 (de) 1986-02-12
PT80375A (en) 1985-05-01
NO851774L (no) 1985-11-05
YU73085A (en) 1988-04-30
JPH0335315B2 (fi) 1991-05-27
HUT37754A (en) 1986-02-28
ES8707182A1 (es) 1987-07-16
RO91141A (ro) 1987-06-30
KR870000497B1 (ko) 1987-03-12
FI851756L (fi) 1985-11-05
ES542813A0 (es) 1986-07-16
PT80375B (pt) 1987-09-30
RO91141B (ro) 1987-07-03
RO94455A (ro) 1988-06-30
RO94455B (ro) 1988-07-01
PL147508B1 (en) 1989-06-30
BG60208B2 (en) 1993-12-30
YU44998B (en) 1991-06-30
RU2017729C1 (ru) 1994-08-15
PL257892A1 (en) 1986-10-07
SU1468413A3 (ru) 1989-03-23
ES8609248A1 (es) 1986-07-16
JPS60243068A (ja) 1985-12-03
MW1685A1 (en) 1986-09-10
IE851103L (en) 1985-11-04
AR241159A2 (es) 1991-12-30
MA20424A1 (fr) 1985-12-31
NO163132B (no) 1990-01-02
ZW7885A1 (en) 1985-07-24
CS320285A2 (en) 1987-03-12
ZA853324B (en) 1986-12-30
PL145416B1 (en) 1988-09-30
AR241159A1 (es) 1991-12-30
FI851756A0 (fi) 1985-05-03
OA08098A (fr) 1987-03-31
NO163132C (no) 1990-04-11
EG17193A (en) 1990-08-30
KR850008154A (ko) 1985-12-13
IN161509B (fi) 1987-12-19
PL253203A1 (en) 1986-06-17

Similar Documents

Publication Publication Date Title
KR860001873B1 (ko) 3-치환된 2-옥신돌-1-카르복스아미드의 제조방법
EP0175551B1 (en) Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
DK162644B (da) N,3-disubstituerede 2-oxindol-1-carboxamid-derivater og 2-oxindol-1-carboxamid-forbindelser til anvendelse som mellemprodukter ved deres fremstilling
JP4861829B2 (ja) ピラゾール誘導体およびオレキシン受容体拮抗薬としてのこれらの使用
US4721712A (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4658037A (en) Intermediates for 1,3-disubstituted 2-oxindoles as analgesic and antiinflammatory agents
EP0153818B1 (en) 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
KR860001874B1 (ko) 2-옥스인돌-1-카복스 아미드의 제조방법
CS252828B2 (en) Method of n,3-disubstituted 2-oxindole-1-carboxamides production
KR870000289B1 (ko) 2-옥스인돌 유도체의 제조방법
JP2794640B2 (ja) イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤
JPS60209564A (ja) 鎮痛性抗炎症剤として有効な、2‐オキシインドール‐1‐カルボキサミド化合物
US4730004A (en) Analgesic and anti-inflammatory 1-acyl-2-oxindole-3-carboxamides
US4791131A (en) Analgesic and antiinflammatory 1-acyl-2-oxindole-3-carboxamides
EP0511021A1 (en) Novel thiazole derivatives
CS252847B2 (cs) Způsob výroby N,3-disubstituovaných 2-oxindol-1-karboxamidů
FI81796C (fi) Foerfarande foer framstaellning av en 1,3-disubstituerad 2-oxindolfoerening som fungerar som ett analgetiskt och anti-inflammatoriskt aemne.
CS252498B2 (cs) Způsob výroby 1,3-disubstituovaných 2-oxindoiů
IE850288L (en) Analgesic oxindoles.
JPS5883681A (ja) 4−シクロアルキルアミノキナゾリン誘導体
BG60375B2 (bg) Заместени на 3-то място 2-оксиндол-1-карбоксамиди като аналгетични и противовъзпалителни вещества
HU211665A9 (hu) Az átmeneti oltalom az 1-19. igénypontokra vonatkozik.

Legal Events

Date Code Title Description
MK4A Patent expired

Effective date: 20000504